Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 86 (5) , 590-592
- https://doi.org/10.1016/s0002-9149(00)01027-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and functionJournal of the American College of Cardiology, 1999
- Ambulatory—not office—blood pressures decline during hormone replacement therapy in healthy postmenopausal womenAmerican Journal of Hypertension, 1998
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal WomenJAMA, 1995
- Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal WomenAnnals of Internal Medicine, 1994
- A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in womenJournal of Clinical Epidemiology, 1994
- Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogenAmerican Journal of Obstetrics and Gynecology, 1992
- Smoking Eliminates the Protective Effect of Oral Estrogens on the Risk for Hip Fracture among WomenAnnals of Internal Medicine, 1992
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Cigarette Smoking, Serum Estrogens, and Bone Loss during Hormone-Replacement Therapy Early after MenopauseNew England Journal of Medicine, 1985